http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CR-20120071-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc549e22cd9a276d9e14cf1feeca599e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
filingDate 2012-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a08dc09572c364201a1871b6fe82a6f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e875c88cdf7f6a7429fa9b8247a17cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52f41e5ebc480f4da4e7d6800da20162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e9086884ecf4e0864515ee0e56cdeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8505e1a3c414c6b5cb66b54473c859f2
publicationDate 2012-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CR-20120071-A
titleOfInvention OCTASACÁRIDOS N-ACILOS ACTIVADORES OF THE FGF RECEPTORS, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
abstract Octasaccharides N-acyl activators of the FGF receptors, which respond to formula (I): in which R1 represents an O-alkyl group optionally substituted with one or more aryl or cycloalkyl groups, R2 represents an OSO3 or hydroxyl group, R3 represents an alkyl, cycloalkyl or alkyl-cycloalkyl group, and R4 represents a disaccharide of formula (II), R6 represents a disaccharide of formula (III) and R8 represents a disaccharide of formula (IV), in which R5, R7 and R9 represent the OSO3 or hydroxyl groups: Its preparation and its application in therapeutics.
priorityDate 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 29.